Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Myasthenia Gravis × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Vomiting 1 Vascular Malformations 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Prostatic Neoplasms 1 Neoplasms 1 Nausea 1 Myasthenia Gravis 1 Microbiota 1 Melanoma 1 Lymphangioma 1 Hepatitis B 1 Hand-Foot Skin Reaction (HFSR) 1 Glioblastoma 1 Erectile Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Pyridostigmine Bromide 4 Tacrolimus 2 Prednisone 2 Mycophenolic Acid 2 tocilizumab 1 sargramostim 1 Thymectomy 1 Tablets 1 Steroids 1 Sternotomy 1 Rituximab 1 Methylprednisolone 1 Methotrexate 1 Immunosuppressive Agents 1 Immunoglobulins, Intravenous 1 HBM9161 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Exercise 1 Cyclosporine 1 Cyclophosphamide 1 Azathioprine 1 Amifampridine 1 Alkalies 1 Albuterol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03914638 2020-04-06

BETA-MG

University of Aarhus

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡